{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/IRD/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T09:53:30.513Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3341,"canonical_name":"Opus Genetics, Inc.","cik":"0001228627","uei":null,"lei":null,"duns":null,"ticker":"IRD"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":34},"count":34,"timeline":[{"ts":"2026-09-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Opus Genetics, Inc. — 2026-09-11","url_slug":"/sec/cik-0001228627/8-k/0001140361-26-036277","accession_number":"0001140361-26-036277","importance":35},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — Opus Genetics, Inc. — 2026-09-11","url_slug":"/sec/cik-0001228627/4/0001140361-26-036347","accession_number":"0001140361-26-036347","importance":30},{"ts":"2026-09-09","kind":"sec.insider.m","reporter":"Magrath George","title":"Chief Executive Officer","shares":392157,"price_per_share":1.15,"usd_value":450981,"security_title":"Common Stock","importance":15.45098055},{"ts":"2026-09-09","kind":"sec.insider.f","reporter":"Magrath George","title":"Chief Executive Officer","shares":75541,"price_per_share":5.97,"usd_value":450980,"security_title":"Common Stock","importance":15.45097977},{"ts":"2026-06-17","kind":"sec.filing","form_type":"424B2","title":"424B2 — Opus Genetics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001228627/424b2/0001140361-26-025525","accession_number":"0001140361-26-025525","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Opus Genetics, Inc. — 2026-06-16","url_slug":"/sec/cik-0001228627/8-k/0001140361-26-025363","accession_number":"0001140361-26-025363","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Opus Genetics, Inc. — 2026-06-16","url_slug":"/sec/cik-0001228627/8-k/0001140361-26-025440","accession_number":"0001140361-26-025440","importance":35},{"ts":"2026-06-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Opus Genetics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001228627/effect/9999999995-26-002021","accession_number":"9999999995-26-002021","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"S-3","title":"S-3 — Opus Genetics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001228627/s-3/0001140361-26-024283","accession_number":"0001140361-26-024283","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — Opus Genetics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001228627/schedule-13d-a/0001193125-26-233062","accession_number":"0001193125-26-233062","importance":70},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — Opus Genetics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001228627/4/0002042266-26-000001","accession_number":"0002042266-26-000001","importance":30},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Foundation Fighting Blindness Retinal Degeneration Fund","title":null,"shares":1700000,"price_per_share":4.35,"usd_value":7395000,"security_title":"Common Stock","importance":42.394999999999996},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Foundation Fighting Blindness, Inc.","title":null,"shares":1700000,"price_per_share":4.35,"usd_value":7395000,"security_title":"Common Stock","importance":42.394999999999996},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Opus Genetics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001228627/schedule-13g/0001727492-26-000010","accession_number":"0001727492-26-000010","importance":55},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Opus Genetics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001228627/schedule-13g-a/0001104659-26-062694","accession_number":"0001104659-26-062694","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Opus Genetics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001228627/schedule-13g-a/0001193125-26-226555","accession_number":"0001193125-26-226555","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"S-8","title":"S-8 — Opus Genetics, Inc. — 2026-05-14","url_slug":"/sec/cik-0001228627/s-8/0001628280-26-035079","accession_number":"0001628280-26-035079","importance":30},{"ts":"2026-05-13","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Opus Genetics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001228627/schedule-13g/0000919574-26-002950","accession_number":"0000919574-26-002950","importance":55},{"ts":"2026-05-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Opus Genetics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001228627/schedule-13g-a/0001791917-26-000005","accession_number":"0001791917-26-000005","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Opus Genetics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001228627/10-q/0001628280-26-034084","accession_number":"0001628280-26-034084","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Opus Genetics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001228627/8-k/0001628280-26-033856","accession_number":"0001628280-26-033856","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — YERXA BENJAMIN R — 2026-04-27","url_slug":"/sec/cik-0001145910/4/0000905148-26-001867","accession_number":"0000905148-26-001867","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — SCHACHLE JOSEPH K — 2026-04-27","url_slug":"/sec/cik-0001145914/4/0000905148-26-001866","accession_number":"0000905148-26-001866","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — Opus Genetics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001228627/4/0000905148-26-001862","accession_number":"0000905148-26-001862","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — Opus Genetics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001228627/4/0000905148-26-001863","accession_number":"0000905148-26-001863","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — Opus Genetics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001228627/4/0000905148-26-001864","accession_number":"0000905148-26-001864","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — Opus Genetics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001228627/4/0000905148-26-001865","accession_number":"0000905148-26-001865","importance":30},{"ts":"2026-04-23","kind":"sec.insider.s","reporter":"Magrath George","title":"Chief Executive Officer","shares":9511,"price_per_share":5.22,"usd_value":49647,"security_title":"Common Stock","importance":35.04964742},{"ts":"2026-04-23","kind":"sec.insider.s","reporter":"Gagnon Robert E.","title":"Chief Financial Officer","shares":7842,"price_per_share":5.1846,"usd_value":40658,"security_title":"Common Stock","importance":35.0406576332},{"ts":"2026-04-23","kind":"sec.insider.s","reporter":"Jayagopal Ashwath","title":"Chief Scientific & Dev. Ofc.","shares":7542,"price_per_share":5.1917,"usd_value":39156,"security_title":"Common Stock","importance":35.0391558014},{"ts":"2026-04-23","kind":"sec.insider.s","reporter":"YERXA BENJAMIN R","title":"President","shares":7470,"price_per_share":5.2371,"usd_value":39121,"security_title":"Common Stock","importance":35.039121137},{"ts":"2026-04-23","kind":"sec.insider.s","reporter":"SCHACHLE JOSEPH K","title":"Chief Operating Officer","shares":4697,"price_per_share":5.2202,"usd_value":24519,"security_title":"Common Stock","importance":35.0245192794},{"ts":"2026-04-23","kind":"sec.insider.s","reporter":"Zaremba Rabourn Amy","title":"Head of Fin. Quality Assurance","shares":1641,"price_per_share":5.204,"usd_value":8540,"security_title":"Common Stock","importance":35.008539764},{"ts":"2026-04-21","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Opus Genetics, Inc. — 2026-04-21","url_slug":"/sec/cik-0001228627/corresp/0001140361-26-015777","accession_number":"0001140361-26-015777","importance":30}]}